Comprehensive Cardiology Panel
Cardiovascular diseases (CVDs) are the leading cause of death globally, responsible for an estimated 17.9 million lives lost each year. Among these, heart attacks and strokes account for more than four out of five CVD deaths, with one-third occurring prematurely in individuals under 70 years of age. These alarming statistics underscore the critical need for early detection and personalized management of cardiovascular conditions.
Our Comprehensive Cardiology Panel offers a cutting-edge approach to understanding and managing cardiovascular health. By targeting specific genes associated with major cardiovascular disorders, this panel provides a thorough genetic analysis, offering crucial insights into the molecular mechanisms behind various heart conditions. This knowledge empowers healthcare providers and patients to make informed decisions, leading to better preventive measures, therapeutic interventions, and long-term care strategies.
Conditions covered
Aortic aneurysm, hereditary thoracic panel | Catecholaminergic polymorphic ventricular tachycardia panel |
Arrhythmia | Congenital heart defects |
Arrhythmogenic Right Ventricular Cardiomyopathy | Familial hypercholesterolemia |
Brugada syndrome | Heterotaxy |
Cardiomyopathy dilated panel | Hypertrophic Cardiomyopathy |
Individual conditions are also offered
The Comprehensive Cardiology Panel is designed to assess a wide range of genetic factors that contribute to cardiovascular diseases. It utilizes advanced sequencing technologies and sophisticated variant analysis algorithms to identify and interpret genetic variants associated with heart conditions. This detailed genetic analysis is crucial for understanding the risk factors, disease progression, and potential outcomes for patients with cardiovascular disorders.
-
Genetic Sequencing and Analysis: The panel focuses on sequencing genes that are known to be associated with cardiovascular diseases. By analyzing these genes, we can detect mutations or variants that may increase the risk of heart conditions.
-
Variant Interpretation: Not all genetic variants have the same impact on health. Our advanced algorithms categorize these variants based on their clinical significance, allowing healthcare providers to understand which variants are most relevant to the patient’s condition.
-
Molecular Insights: Understanding the genetic basis of cardiovascular diseases provides insights into the underlying molecular mechanisms. This knowledge can help in identifying the pathways involved in disease development, which can be targeted for therapeutic interventions.
Clinical utility:
-
Accurate Diagnosis: Identifies specific genetic variants associated with heart conditions for precise diagnosis.
-
Risk Assessment and Prognosis: Detects genetic variants linked to increased cardiovascular risk, enabling early identification and personalized monitoring.
-
Family Screening and Genetic Counseling: Facilitates screening of family members for risk assessment and enables informed family planning decisions.
-
Research and Advancements: Contributes to ongoing research on the genetic basis of cardiovascular diseases, leading to new discoveries and advancements.
-
Personalized Care: Allows tailored interventions and preventive measures based on individual genetic profiles.
-
Improved Patient Outcomes: Enhances patient care through precise diagnoses and proactive risk management.
When to Consider Cardiology Panel
The Comprehensive Cardiology Panel is recommended for:
-
Individuals with a Family History of Cardiovascular Diseases: If heart conditions such as coronary artery disease, cardiomyopathies, or arrhythmias run in your family, this panel can help in identifying your risk factors.
-
Patients with Unexplained Cardiovascular Symptoms: If you have symptoms such as chest pain, palpitations, or unexplained shortness of breath, the panel can aid in diagnosing potential underlying genetic causes.
-
Early-Onset Cardiovascular Disease: For individuals who develop cardiovascular diseases at a young age, this panel can uncover genetic predispositions that might have contributed to the early onset.
-
Pre-emptive Screening: For those who are asymptomatic but wish to understand their cardiovascular risk, especially if they have other risk factors such as hypertension, diabetes, or high cholesterol.
MapmyGenome Offerings
MapmyGenome’s Comprehensive Cardiology Panel offers a comprehensive genetic analysis tailored to your cardiovascular health needs. Our offerings include:
-
Complete Gene Panel Analysis: We analyze a wide array of genes associated with cardiovascular diseases, ensuring that no significant genetic factors are overlooked.
-
Detailed Report and Interpretation: Each panel comes with a detailed report that includes an interpretation of the genetic variants found, their clinical significance, and personalized recommendations for management and care.
-
Genetic Counseling: We provide access to genetic counselors who can help you understand your results, discuss the implications for your health, and assist with any necessary lifestyle or treatment changes.
-
Family Screening Options: For those concerned about hereditary risks, we offer family screening packages that allow you to assess the cardiovascular risk for your loved ones.
-
Ongoing Support: Cardiovascular health is a lifelong journey. MapmyGenome provides ongoing support to help you manage your heart health effectively, including updates on the latest research and recommendations based on your genetic profile.
Test specifications
Technique | Coverage | Variant types | TAT | Sample requirements |
---|---|---|---|---|
NGS | 150 - 180X | SNP | 3 - 4 weeks | 2 ml EDTA Blood / 2 ug DNA |
Learn more:
Read: Sudden Cardiac Arrest
Listen: Revolutionizing Heart Health
Watch: The Power of Genetic Testing in Cardiovascular Care